LEADER 03899nam 22006252 450 001 9910462941503321 005 20151005020621.0 010 $a1-107-35746-2 010 $a1-107-23541-3 010 $a1-107-34409-3 010 $a1-107-34894-3 010 $a1-107-34784-X 010 $a1-139-08839-4 010 $a1-107-34534-0 010 $a1-107-34159-0 035 $a(CKB)2670000000353220 035 $a(EBL)1139682 035 $a(OCoLC)842882917 035 $a(SSID)ssj0000871893 035 $a(PQKBManifestationID)11474382 035 $a(PQKBTitleCode)TC0000871893 035 $a(PQKBWorkID)10823751 035 $a(PQKB)10420136 035 $a(UkCbUP)CR9781139088398 035 $a(MiAaPQ)EBC1139682 035 $a(Au-PeEL)EBL1139682 035 $a(CaPaEBR)ebr10695360 035 $a(CaONFJC)MIL494732 035 $a(OCoLC)842932646 035 $a(EXLCZ)992670000000353220 100 $a20110519d2013|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aModern bribery law $ecomparative perspectives /$fedited by Jeremy Horder and Peter Alldridge$b[electronic resource] 210 1$aCambridge :$cCambridge University Press,$d2013. 215 $a1 online resource (xvi, 366 pages) $cdigital, PDF file(s) 300 $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). 311 $a1-107-01873-0 320 $aIncludes bibliographical references and index. 327 $aPart I. Bribery Law : between Public Wrongdoing and Private Advantage-Taking -- Reformulating bribery : a legal critique of the Bribery Act 2010 / Bob Sullivan -- Official and commercial bribery : should they be distinguished? / Stuart P. Green -- Countering corrupting conflicts of interest : the example of Hong Kong / David C. Donald -- Part II. Bribery without Borders : tackling Corruption in the EU and Beyond -- Bribery in Italy : an outlook on present laws and perspectives on reform / Roberto Guerrini and Dario Guidi -- Development, business integrity and the UK Bribery Act 2010 / Indira Carr -- The aims and limits of European Union anti-corruption law / Valsamis Mitsilegas -- Deterring bribery : law, regulation and the export trade / Jeremy Horder -- Part III. Ill-Gotten Gains : the Challenge of Prosecution, Enforcement and Asset Recovery -- Bribery and the changing pattern of criminal prosecution / Peter Alldridge -- Bribery and corruption : the UK framework for enforcement Charlie Monteith -- Prosecuting bribery in Hong Kong's human rights environment / Simon N.M. Young -- Is the UNCAC an effective deterrent to grand corruption? Tim Daniel and Tim Maton. 330 $aThe Bribery Act 2010 is the most significant reform of UK bribery law in a century. This critical analysis offers an explanation of the Act, makes comparisons with similar legislation in other jurisdictions and provides a critical commentary, from both a UK and a US perspective, on the collapse of the distinction between public and private sector bribery. Drawing on their academic and practical experience, the contributors also analyse the prospects for enforcement and the difficulties facing lawyers seeking asset recovery following the laundering of the proceeds of bribery. International perspectives are provided via comparisons with the law in Spain, Hong Kong, the USA and Italy, together with broader analysis of the application of the law in relation to EU anti-corruption initiatives, international development and the arms trade. 606 $aBribery$zGreat Britain 615 0$aBribery 676 $a345.41/02323 702 $aHorder$b Jeremy 702 $aAlldridge$b Peter 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910462941503321 996 $aModern bribery law$92484405 997 $aUNINA LEADER 05279nam 2200625Ia 450 001 9910830080403321 005 20230721005135.0 010 $a1-282-12366-1 010 $a9786612123665 010 $a0-470-74546-0 010 $a0-470-74545-2 035 $a(CKB)1000000000719711 035 $a(EBL)427958 035 $a(SSID)ssj0000354420 035 $a(PQKBManifestationID)11273861 035 $a(PQKBTitleCode)TC0000354420 035 $a(PQKBWorkID)10322574 035 $a(PQKB)11567099 035 $a(MiAaPQ)EBC427958 035 $a(OCoLC)352789951 035 $a(EXLCZ)991000000000719711 100 $a20090116d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aManagement of acute coronary syndromes$b[electronic resource] /$fEli V. Gelfand and Christopher P. Cannon 210 $aChichester, West Sussex ;$aHoboken, NJ $cJohn Wiley & Sons$d2009 215 $a1 online resource (242 p.) 300 $aDescription based upon print version of record. 311 $a0-470-72557-5 320 $aIncludes bibliographical references and index. 327 $aManagement of Acute Coronary Syndromes; Contents; List of contributors; Foreword; Chapter 1 Pathophysiology of acute coronary syndromes; Introduction; Formation of atherosclerotic plaque; Plaque instability and the development of ACS; Myocardial ischemia; Thrombus formation; Platelets; Secondary hemostasis; Dynamic obstruction; Progressive mechanical obstruction; Inflammation; Secondary unstable angina; References; Chapter 2 Diagnosis of acute coronary syndrome; Introduction; Definition of myocardial infarction; History; Risk factors; Physical examination; Electrocardiography 327 $aThe pathophysiologic basis of ST segment changes during ischemiaElectrocardiography in ST-elevation MI and identification of the infarct-related artery; Electrocardiography in unstable angina and NSTEMI; Cardiac biomarkers; Noninvasive imaging; Echocardiography; Myocardial perfusion imaging; Coronary computed tomography; Cardiovascular magnetic resonance imaging; Stress testing for diagnosis of ACS; Overall diagnostic pathway for ACS; References; Chapter 3 Unstable angina and non-ST-elevation myocardial infarction; Introduction; Causes of UA/NSTEMI; Presentation of UA/NSTEMI 327 $aGeneral strategies in management of UA/NSTEMIRisk stratification of patients with UA/NSTEMI; Initial management of UA/NSTEMI in the emergency department; Pharmacologic treatment of ischemia in UA/NSTEMI; Beta-blockers; Nitrates; Calcium channel blockers; Angiotensin-converting enzyme inhibitors; Morphine; Oxygen; Invasive versus conservative strategy; Antiplatelet therapy in UA/NSTEMI; Aspirin; Clopidogrel; Prasugrel; Glycoprotein IIb/IIIa inhibitors; Anticoagulant therapy in UA/NSTEMI; Unfractionated heparin; Enoxaparin; Direct thrombin inhibitors; Fondaparinux 327 $aOral anticoagulation in UA/NSTEMIFibrinolysis in UA/NSTEMI; Early lipid-lowering therapy in patients with UA/NSTEMI; Predischarge noninvasive risk stratification after UA/NSTEMI; Overall management of UA/NSTEMI; References; Chapter 4 ST-segment-elevation myocardial infarction; Introduction; Global treatment goals in STEMI; Prehospital management and triage; Transport decisions; Management prior to reperfusion; Primary reperfusion therapy for STEMI; Fibrinolysis; Combination fibrinolysis; Markers of fibrinolysis effectiveness; Complications of fibrinolysis 327 $aPrimary percutaneous coronary interventionComparison of PCI with fibrinolysis; Timing of primary PCI; PCI following fibrinolytic therapy; Rescue PCI; Facilitated PCI; Routine PCI after successful fibrinolysis; Overall reperfusion strategy; Coronary artery bypass grafting for treatment of STEMI; Adjunctive pharmacologic treatment of STEMI; Antiplatelet agents; Anticoagulation therapy; Other adjunctive therapy; Hospital care following successful reperfusion; References; Chapter 5 Special considerations in acute coronary syndromes; Secondary unstable angina 327 $aAcute coronary syndrome in patients with diabetes mellitus 330 $aAcute Coronary Syndrome covers the spectrum of clinical conditions ranging from unstable angina to non-ST elevation myocardial infarction and ST elevation myocardial infarction. These life-threatening disorders are a major cause of emergency medical care, hospitalization and mortality. Management of Acute Coronary Syndromes is designed to provide busy clinicians with a comprehensive guide to the investigation, diagnosis and treatment of these syndromes. It encompasses the latest technologies, including the use of biomarkers and non-invasive imaging procedures. For each condition, t 606 $aCoronary heart disease 606 $aMyocardial infarction 615 0$aCoronary heart disease. 615 0$aMyocardial infarction. 676 $a616.123 676 $a616.12306 700 $aGelfand$b Eli V$01672752 701 $aCannon$b Christopher P$0893564 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830080403321 996 $aManagement of acute coronary syndromes$94036305 997 $aUNINA